Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/enbJCfbwocfEgzzhciFE

March 12, 2013News for medical technology professionals

  Top Story 
 
  • Invendo gets FDA OK for single-use colonoscopy device
    Invendo medical has received 510(k) clearance from the FDA for its C20 colonoscopy device along with the company's SC20 colonoscope, a handheld tool designed to be used with computer-aided technology that will minimize stress on the colon wall. The devices have been installed for the first time in the U.S. at two facilities in New York. BeckersASC.com (3/11) LinkedInFacebookTwitterEmail this Story
Document Control Made Easy
BSI's web-based solution significantly reduces the cost and effort needed to effectively manage documents, performance, and sustainability activities within your quality management system. It gives transparency and control across your entire organization.
To learn more, download case studies.
  Business & Market Trends 
 

Some of the best and brightest business and scientific minds will gather for Plastics News' Plastics in Medical Devices conference, May 13-15 in Boston. A strong program features Becton Dickinson, Boston Scientific, Covidien, Edward Lifesciences, MassMEDIC, Philips Respironics, Phillips-Medisize Corp., UMass Lowell and Ximedica, among others. See the full agenda and register.

  International Developments 
 
What if a significant amount of your sales are derived from off-label use of your product?
Off-label promotion and off-label use should not be confused. There are risk management precautions you can take. This quick "Ask and Expert" will help you understand the basics. Read More.

  Science & Health 
 
The New You Starts Here.
Designed for busy healthcare professionals, FIU's online Healthcare MBA is transformative. Graduates emerge ready for a leadership role in healthcare, with a clear vision of how to lead collaboratively and advance the business of healthcare. Classes begin Fall 2015. Start here.

  Emerging Technologies 
  • St. Jude releases device to promote personalized stenting
    A next-generation device intended to help doctors tailor stenting decisions to the individual patient's anatomy and disease state has been released by St. Jude Medical. The company said the Ilumien Optis System is the only such device that combines fractional flow reserve and intravascular optical coherence tomography imaging into a single unit. RTT News (3/11) LinkedInFacebookTwitterEmail this Story
  • New MRI scanner from Philips allows imaging of more patients
    Philips has introduced the Multiva 1.5T MRI scanner for use in diffusion tensor imaging, magnetic resonance spectroscopy and related procedures. The device, unveiled at a cardiology meeting, includes the firm's FlexStream workflow and is designed to reduce pre-scan setup time by up to 40%, which will allow imaging of more patients. MedGadget.com (3/11) LinkedInFacebookTwitterEmail this Story
 
The Buzz(CORPORATE ANNOUNCEMENTS)

Interested in learning more about advertising with SmartBrief? Click here for detailed industry information and media kits. 

  Government & Regulatory 
 
Don't lose access to your customer's facility. We can help.
Rep-Clear: Watermark's Solution for ensuring access to your customers. Rep-Clear includes our proprietary platform for tracking all items associated with a Rep and our professional support staff to provide individual service, ensuring all items are up to date and access to a facility is not lost. View common rep excuses.

AdvaMed News 
  • Molecular Diagnostics
    Wednesday, June 5 – Thursday, June 6
    Sheraton Crystal City, Arlington, Va.
    In this meeting, FDA and industry speakers will address current regulatory, reimbursement and legislative topics in the evolving field of molecular diagnostics in an interactive two-day program. Attendees will participate in sessions ranging from the latest government policies aimed at molecular diagnostics, health care reform and implications for diagnostics; FDA oversight and regulation of molecular diagnostics; key regulatory considerations in developing molecular diagnostics and what it takes to make to create a good submission; developments impacting personalized medicine; co-development and the future of companion diagnostics; the changing landscape of molecular diagnostics reimbursement; and an afternoon on future proposals that could foster the introduction of new molecular diagnostics. Visit MTLI online for more information. LinkedInFacebookTwitterEmail this Story
  • Join the AdvaMed-MTLI LinkedIn group!
    Build close relationships with member companies, both small and large, and receive an intimate understanding of the key issues affecting innovation, access and the bottom line. Interact in discussions that leverage the leadership and expertise of the medical technology industry. This social group is full of key stakeholders, influencers and industry thought leaders as well as regulatory and policy experts from the FDA and CMS. Aside from practical learning opportunities, this LinkedIn group provides the premier opportunity to network with key players from virtually every aspect of the industry. Link to the AdvaMed MTLI LinkedIn group page. LinkedInFacebookTwitterEmail this Story
 
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom

 
Position TitleCompany NameLocation
Sales Area Manager/Sales Rep of Neurovascular Intervention ProductsAsahi Intecc USA, Inc.Any location in US, CA
Project Manager, Regulatory Affairs - Transfusion Medicine Johnson & JohnsonRaritan, NJ
Associate CounselACell, Inc.Columbia, MD
Compliance Consultant 2DJO GlobalVista, CA
Accreditation ManagerAmerican Association of Tissue BanksMcLean, VA
REGULATORY AFFAIRS SPECIALISTMasimo CorporationIrvine, CA
Director, Health Care ComplianceRTI BiologicsAlachua, FL
Manager, HCL Regulatory & Quality ComplianceOwens & MinorLouisville, KY
DIR OPERATIONS, Milpitas Site - 130000007RAbbott San Jose, CA
Biostatistician - Post Market Surveillance Johnson & JohnsonRaynham, MA
Click here to view more job listings.

  SmartQuote 
We are all worms. But I do believe that I am a glow-worm."
--Winston Churchill,
British prime minister


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Lisa Gough
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information